Strides Pharma Quarterly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Sep-2022	Jun-2022	Mar-2022	Dec-2021
Gross Sales	864.85	897.10	940.07	866.02	794.39
Excise Duty	--	--	--	--	--
Net Sales	864.85	897.10	940.07	866.02	794.39
Other Operating Income	--	--	--	--	--
Other Income	67.76	56.55	13.55	86.06	10.19
Total Income	932.61	953.65	953.62	952.08	804.58
Total Expenditure	891.96	843.81	1002.09	944.44	832.57
PBIDT	40.65	109.84	(48.46)	7.64	(27.99)
Interest	58.44	67.64	54.54	49.48	42.25
PBDT	(17.80)	42.20	(103)	(41.85)	(70.24)
Depreciation	60.22	61.70	60.40	60.68	60.90
Minority Interest Before NP	--	--	--	--	--
Tax	(2.08)	(18.12)	4.16	(154.52)	(1.87)
Deferred Tax	6.17	(20.29)	(32.23)	23.04	(2.61)
Reported Profit After Tax	(82.11)	18.90	(135.33)	28.96	(126.66)
Minority Interest After NP	(2.08)	(3.92)	0.56	(0.26)	(4.99)
Net Profit after Minority Interest	(80.03)	22.83	(135.89)	29.22	(121.67)
Extra-ordinary Items	38.28	33.09	(64.10)	(59.66)	(15.43)
Adjusted Profit After Extra-ordinary item	(118.31)	(10.26)	(71.79)	88.88	(106.24)
EPS (Unit Curr.)	(8.86)	2.54	(15.13)	3.25	(13.55)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	90.29	90.29	89.79	89.79	89.78
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	4.70	12.24	(5.16)	0.88	(3.52)
PBDTM(%)	(2.06)	4.70	(10.96)	(4.83)	(8.84)
PATM(%)	(9.49)	2.11	(14.40)	3.34	(15.94)